Tumour-Treating Fields (TTFields): Investigations on the Mechanism of Action by Electromagnetic Exposure of Cells in Telophase/cytokinesis

Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis

Tumour-treating fields (TTFields) use alternating electric fields which interfere with dividing cells, thereby reducing tumour growth. Previous reports suggest that electrical forces on cell structure proteins interfered with the chromosome separation during mitosis and induced apoptosis. In the present report we evaluate electromagnetic exposure of cells in telophase/cytokinesis in order to further analyse the mechanism of action on cells. We p…

Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting

BAAR, Switzerland--(BUSINESS WIRE)--May 31, 2025-

#Novocure?s Tumor Treating Fields Therapy Shows Promise but Faces Competitive Pressure in Pancreatic Cancer Market

As the fight against pancreatic cancer continues, Novocure Limited (NASDAQ: NVCR) has made significant strides in its development of Tumor Treating Fields (TTFields) therapy. The company announced that results from the Phase 3 PANOVA-3 trial of TTFields for pancreatic cancer will be unveiled at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, with additional publication in the Journal of Clinical Oncology…

Tumor-Treating Fields With Chemo Improves OS in Pancreatic Cancer

In the phase 3 PANOVA-3 trial, patients who underwent tumor-treating fields therapy had extended overall survival vs standard-of-care gemcitabine plus nab-paclitaxel.

Tumor Treating Fields Boost Survival in Locally Advanced Pancreatic Cancer

TTFields offers “a potential treatment advance” in pancreatic cancer, a new study finds.